Great Britain approves Lecanemab for Alzheimer’s disease

Great Britain approves Lecanemab for Alzheimer’s disease

0 Comments

/Ralf, stock.adobe.com London The drug Lecanemab for the treatment of early Alzheimer’s disease has received approval for certain patient groups in Great Britain from the British Medicines and Healthcare products Regulatory Agency (MHRA). According to

FDA approves vorasidenib for treatment of gliomas

FDA approves vorasidenib for treatment of gliomas

0 Comments

medicine Wednesday, August 7, 2024 Boston – The US Food and Drug Administration (FDA) has approved the active ingredient vorasidenib for patients with grade 2 gliomas with an IDH1 or IDH2 mutation. The basis for

FDA approves another antibody to treat the disease...

FDA approves another antibody to treat the disease…

0 Comments

/Sebastian Kaulitzki, stockadobe.com Silver Spring/Maryland – The US Food and Drug Administration (FDA) has approved aducanumab (Aduhelm, 2021), which is no longer available on the market, and lecanemab (Leqembi, 2023), a third monoclonal antibody for